BCV
FLGT icon

Banque Cantonale Vaudoise’s Fulgent Genetics FLGT Stock Holding History

Banque Cantonale Vaudoise’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,153
Closed -$36K – 1200
2023
Q1 		$36K Hold
1,153
– – ﹤0.01% 1003
2022
Q4 		$34K Hold
1,153
– – ﹤0.01% 1005
2022
Q3 		$44K Hold
1,153
– – ﹤0.01% 1009
2022
Q2 		$63K Buy
1,153
+535
+87% +$29.4K ﹤0.01% 960
2022
Q1 		$39K Hold
618
– – ﹤0.01% 1077
2021
Q4 		$62K Hold
618
– – ﹤0.01% 1035
2021
Q3 		$56K Buy
618
+186
+43% +$16.9K ﹤0.01% 1031
2021
Q2 		$40K Buy
+432
New +$34.5K ﹤0.01% 1069

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Banque Cantonale Vaudoise's FLGT Position: Q2 2023 in Review

Banque Cantonale Vaudoise sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 1,153 shares — an estimated $36K sold.

Banque Cantonale Vaudoise first reported a position in FLGT in Q2 2021 and held it in 8 quarters. The position peaked at $63K in Q2 2022. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • Banque Cantonale Vaudoise reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,153 Fulgent Genetics shares in Q2 2023, an estimated $36K.
  • Banque Cantonale Vaudoise first reported a position in Fulgent Genetics in Q2 2021 and held it in 8 quarters.
  • Banque Cantonale Vaudoise's Fulgent Genetics position peaked at $63K in Q2 2022.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2023, filed 9 Aug 2023.